Streetbeat News

Revenues

VTR

Ventas has entered agreements with Kindred and ScionHealth concerning 23 long-term acute care hospitals. The lease term is set to mature on April 30, with an initial annualized cash contractual base rent of $80 million starting May 1, 2025. Rent will escalate annually by 2.75% through April 30, 2030.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:34 pm

SPY

The NY Empire State Manufacturing Index for September reported a significant increase to 11.5, surpassing the estimated -4.1. This unexpected rise indicates a stronger manufacturing sector in New York, which could positively influence market sentiment.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:30 pm

BOSC

BOS Better Online Solutions Ltd. (NASDAQ:BOSC) has received a $900,000 order from an Israeli aerospace customer, to be delivered through 2024. This highlights BOSC's reliability and quality in supply chain services.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:29 pm

BIVI

BioVie has received approval from the U.S. Army Medical Research and Development Command to evaluate its drug Bezisterim for Long Covid. The company also secured $13.1 million in funding.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:27 pm

TOVX

Theriva Biologics (NYSE:TOVX) has been awarded €2.28 million from the Spanish government's National Knowledge Transfer Program to support a collaboration with Universitat Autònoma de Barcelona. The funding will advance Theriva's suspension cell platform for manufacturing virus therapies.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:24 pm

IDCC

InterDigital, Inc. (NASDAQ:IDCC) has set ambitious financial targets for 2030, aiming for $1 billion in annual recurring revenue and $600 million in adjusted EBITDA. This reflects the company's growth strategy in mobile, video, and AI technology R&D.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:07 pm

CODA

Coda Octopus Group reported Q3 2024 earnings per share of $0.11, surpassing the analyst estimate of $0.08 by 37.5%. The company's sales were $5.476 million, exceeding the expected $5.419 million and marking an 11.98% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 12:02 pm

GTLS

Chart Industries (NYSE:GTLS) has received mixed analyst ratings, with a decrease in the average 12-month price target from $192.88 to $174.88. Analysts have adjusted their ratings and price targets in response to market conditions and company performance. Despite a strong revenue growth rate of 14.56%, the company faces challenges with profitability, debt management, and returns on equity and assets.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 12:00 pm

TBPH

Theravance Biopharma (NASDAQ:TBPH) has received mixed analyst ratings over the past three months, with a recent average price target of $12.25, down from $15.00. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. Theravance Biopharma is a biopharmaceutical company focused on organ-selective medicines, with a recent revenue growth rate of 3.69% and a net margin of -115.94%.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 12:00 pm

INTC

Intel shares are rising due to reports that the company may receive up to $3.5 billion in funding for US military chip production.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 11:51 am